 |
 |
Dear Ms. Mixson Jenkins: Thank you for contacting the UCB, Inc. Medical Affairs Department with your request for information regarding Neupro® (rotigotine transdermal system). Specifically, your message states, “Our support groups in very interested in having someone from your company speak at our July 18, 2007 or Aug 1, 2007, meeting about Neupro. We meet at 1:00 pm at Effingham County Hospital in Springfield, GA.” Neupro® is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson’s disease. Please review the enclosed package insert for approved indication and complete prescribing information. (are they assuming we are old onset) Unfortunately, our company policy prohibits employees from speaking to patient groups. ( OK, they cant talk to us but they want us to use their product) We suggest that you contact one of the following organizations to find a local expert: OK, contact the major PD organizations to find a local expert, Is that a doctor who they will pay $500.00 to speak about their product or would that be someone like Michelle Lane who started the patch in 2002 for Schwarz Pharma and was one of the first to do so. Think they will pay her? Had to let off some steam, I hope one of their reps are in Chicago next week I will show him this letter. Kay ************************************** See what's free at http://www.aol.com.